The study focuses on the protein ZBTB16. This molecule is not unknown in research and occurs in various tissues of the body. What is new, however, is the discovery that ZBTB16 performs a special protective function in the heart – specifically in the blood vessels.
ZBTB16 is not exclusively a heart-specific protein.
ZBTB16 is not a protein that is found exclusively in the heart. It also plays important roles in the immune system, in metabolism, and in cellular development. However, the new study shows that ZBTB16 is of crucial importance for heart health specifically in the endothelium of the cardiac blood vessels. In this location in particular, it appears to help determine how well the heart copes with the ageing process.
This distinction is important: the researchers are not describing a newly discovered heart-specific substance, but rather a newly identified and previously underestimated function of a well-known protein in a highly sensitive site.
Blood vessels as an active control centre
The innermost cell layer of the blood vessels, the endothelium, does more than just supply the heart with oxygen and nutrients. It actively communicates with other cell types in the heart - cardiomyocytes, connective tissue cells, and nerve fibers. These signals are crucial for the heart’s structure, function, and adaptability.
The study shows that as we age, the activity of ZBTB16 in these endothelial cells drops significantly. This alters the signals sent by the blood vessels, disrupting the balance within the heart tissue.
When the protective mechanism is removed
In animal experiments, the researchers were able to show the effects of losing ZBTB16 in the endothelium. Even in young mice, reduced levels of ZBTB16 caused changes typically seen in older hearts. The heart became stiffer, connective tissue accumulated, cardiomyocytes enlarged, and the fine nerve network within the heart diminished. The relaxation phase of the heart was particularly affected—precisely the aspect of cardiac function that is often impaired with age. These changes resemble those observed in the common form of heart failure with preserved ejection fraction (HFpEF).
A molecule that restrains damaging processe
ZBTB16 acts as a regulator in the endothelium. It helps keep vascular cells healthy and prevents them from releasing harmful signaling molecules. Without this protective effect, processes are triggered that promote inflammation, tissue remodeling, and scarring.
The researchers showed that ZBTB16 suppresses other molecules that would otherwise encourage connective tissue formation and functional impairments in the heart. In the absence of ZBTB16, the endothelial environment shifts toward an accelerated aging process.
Age-related changes are partly reversible
A central finding of the study is that these processes can be influenced, at least in part. In older mice, ZBTB16 was specifically reactivated only in the heart’s vascular cells.
The result: heart function improved measurably. Relaxation capacity increased, fibrotic changes decreased, and markers of cellular aging were reduced. These experiments demonstrate that age-related changes in the heart are not necessarily irreversible.
Blood vessels are more than just supply structures
The results provide new insights into the mechanisms of heart aging and highlight the active role of blood vessels in the heart. They also explain why potential therapeutic approaches must be highly targeted. Because ZBTB16 is present in many tissues throughout the body, nonspecific manipulation could be problematic. Even more important, the study demonstrates that targeting ZBTB16 specifically in the heart’s endothelium is sufficient to achieve beneficial effects.
“Our findings show that the vascular system in the heart is far more than a mere supply network,” says the senior author of the study. “Understanding how these vascular cells change with age opens up new possibilities for specifically influencing heart aging.”
Further studies are needed before these findings can be applied to humans. Nevertheless, this work provides an important foundation for better understanding age-related heart failure and for developing new long-term treatment strategies.
The study was published in the journal European Heart Journal.
Original publication:
Stilz KA, Leonard VE, Rodriguez Morales D, et al. Endothelial ZBTB16: a molecular shield against cardiac aging. Eur Heart J. Published online January 6, 2026. doi:10.1093/eurheartj/ehaf1063
